ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $21,126 | -68.9% | 13,287 | +22.0% | 0.00% | -100.0% |
| Q4 2022 | $67,851 | -60.6% | 10,891 | -68.3% | 0.00% | 0.0% |
| Q4 2021 | $172,000 | -91.8% | 34,327 | -65.3% | 0.00% | -92.3% |
| Q2 2021 | $2,092,000 | -32.1% | 98,918 | -9.9% | 0.01% | -38.1% |
| Q1 2021 | $3,080,000 | +296.9% | 109,815 | +267.8% | 0.02% | +162.5% |
| Q4 2020 | $776,000 | -60.2% | 29,861 | -43.1% | 0.01% | -66.7% |
| Q3 2020 | $1,949,000 | +72.9% | 52,436 | +138.8% | 0.02% | +50.0% |
| Q2 2020 | $1,127,000 | -39.7% | 21,960 | -30.0% | 0.02% | -44.8% |
| Q4 2019 | $1,870,000 | -46.0% | 31,356 | -66.8% | 0.03% | -46.3% |
| Q3 2019 | $3,462,000 | -20.2% | 94,434 | +1.3% | 0.05% | -28.9% |
| Q2 2019 | $4,338,000 | +57.1% | 93,259 | +35.6% | 0.08% | +72.7% |
| Q1 2019 | $2,761,000 | – | 68,770 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |